MMT starts showed a nonsignificant drop at the onset of the PHE (−22.47 per 100,000 Medicaid enrollees; 95 % CI, −50.99 to 6.04), but a significant trend change of 1.41 per 100,000 (95 % CI, 0.37 to 2.46) that reversed the pre-PHE trend to a post-PHE trend of 1.14 per 100,000 (95 % CI, 0.12 to 2.15).
← all excerpts
Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic.
1
—
—